Investigational Drug Information for Emodepside
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
What is the drug development status for Emodepside?
Emodepside is an investigational drug.
There have been 6 clinical trials for Emodepside.
The most recent clinical trial was a Phase 1 trial, which was initiated on August 30th 2021.
The most common disease conditions in clinical trials are Ancylostomiasis, Filariasis, and Hookworm Infections. The leading clinical trial sponsors are Bayer, Drugs for Neglected Diseases, and Bill and Melinda Gates Foundation.
There are one hundred and thirty-eight US patents protecting this investigational drug and two international patents.
Summary for Emodepside
| US Patents | 138 |
| International Patents | 2,795 |
| US Patent Applications | 956 |
| WIPO Patent Applications | 430 |
| Japanese Patent Applications | 356 |
| Clinical Trial Progress | Phase 1 (2021-08-30) |
| Vendors | 23 |
Recent Clinical Trials for Emodepside
| Title | Sponsor | Phase |
|---|---|---|
| Efficacy and Safety of Emodepside in Adults Infected With Hookworm | Public Health Laboratory Ivo de Carneri | Phase 2 |
| Efficacy and Safety of Emodepside in Adults Infected With Hookworm | Jennifer Keiser | Phase 2 |
| Emodepside Phase II Trial for Treatment of Onchocerciasis | Bayer | Phase 2 |
Clinical Trial Summary for Emodepside
Top disease conditions for Emodepside
Top clinical trial sponsors for Emodepside
US Patents for Emodepside
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Emodepside | See Plans and Pricing | Six-membered C--N-bonded aryl sulphide and aryl sulphoxide derivatives as pesticides | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (Monheim am Rhein, DE) | See Plans and Pricing |
| Emodepside | See Plans and Pricing | Method for formulating large diameter synthetic membrane vesicles | Pacira Pharmaceuticals, Inc. (San Diego, CA) | See Plans and Pricing |
| Emodepside | See Plans and Pricing | Anthelmintic compounds | MERIAL INC. (Duluth, GA) | See Plans and Pricing |
| Emodepside | See Plans and Pricing | Pyrazolopyridine sulfonamides as nematicides | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (Monheim am Rhein, DE) | See Plans and Pricing |
| Emodepside | See Plans and Pricing | Anthelmintic depsipeptide compounds | MERIAL, INC. (Duluth, GA) | See Plans and Pricing |
| Emodepside | See Plans and Pricing | 2-(het)aryl-substituted fused bicyclic heterocycle derivatives as pesticides | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (Monheim am Rhein, DE) | See Plans and Pricing |
| Emodepside | See Plans and Pricing | Substituted guanidines as fungicides | Nippon Soda Co., Ltd. (Tokyo, JP) | See Plans and Pricing |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Emodepside
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Emodepside | Australia | AU2015286634 | 2034-07-11 | See Plans and Pricing |
| Emodepside | Brazil | BR112017000398 | 2034-07-11 | See Plans and Pricing |
| Emodepside | China | CN106659720 | 2034-07-11 | See Plans and Pricing |
| Emodepside | European Patent Office | EP3177291 | 2034-07-11 | See Plans and Pricing |
| Emodepside | Japan | JP2017519802 | 2034-07-11 | See Plans and Pricing |
| Emodepside | World Intellectual Property Organization (WIPO) | WO2016005576 | 2034-07-11 | See Plans and Pricing |
| Emodepside | Brazil | BR112017002359 | 2034-08-13 | See Plans and Pricing |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
